ArticleFrontiers in medicine2026
Local methylprednisolone irrigation and tolerability after PTS-based bronchoscopic treatment for malignant central airway obstruction: a retrospective study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malignant central airway obstruction (MCAO) is a severe complication of advanced thoracic malignancies. Bronchoscopic intervention combined with intralesional para-toluenesulfonamide (PTS) injection can restore airway patency, but local mucosal inflammation after treatment may cause pain, edema, and poor early tolerability. This study assessed whether local methylprednisolone irrigation after PTS-based bronchoscopic treatment improves short-term outcomes in patients with MCAO. Methods: We retrospectively analyzed 88 treatment sessions from 35 consecutive patients who underwent bronchoscopic intervention plus intralesional PTS injection between January 2024 and December 2025. According to the irrigation solution used after PTS injection, sessions were divided into methylprednisolone and normal saline groups. Outcomes at 72 h included cough score, mMRC dyspnea score, airway stenosis score, pain score, mucosal edema, and bleeding. Linear mixed-effects models and generalized estimating equations were used to account for repeated treatment sessions, and inverse probability of treatment weighting was applied to adjust for baseline differences. Results: Bronchoscopic intervention plus PTS injection significantly improved cough, dyspnea, and airway stenosis at 72 h. Compared with normal saline, methylprednisolone irrigation did not provide additional improvement in these short-term efficacy outcomes. However, methylprednisolone irrigation was associated with lower post-procedural pain and less mucosal edema, without increasing bleeding risk. These findings remained consistent after weighting, sensitivity analyses, and false discovery rate correction. Conclusion: Local methylprednisolone irrigation after PTS-based bronchoscopic treatment may improve early procedural tolerability in patients with MCAO by reducing post-procedural pain and mucosal edema, rather than enhancing short-term airway-opening efficacy. Further prospective studies are needed to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.